跳至主要内容
临床试验/NCT00771862
NCT00771862终止4 期

Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study

University of California, San Diego2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2008年10月最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
入组人数
16
试验地点
2
主要终点
The primary outcome measurement will be the difference in average NRS (as administered as part of the Brief Pain Inventory) at 4 weeks between the two treatment groups.

研究概览

简要总结

The purpose of this research study is to determine if putting local anesthetic through one or two percutaneous catheters placed next to the nerves that go to an amputated limb will decrease long-term pain in the amputated limb.

详细描述

Specific Aim 1: To determine if, compared with current and customary analgesia, the addition of multiple-day ambulatory continuous peripheral nerve blocks decrease the incidence and severity of post-amputation phantom limb and stump pain.

Hypothesis 1: Following upper or lower extremity amputation, the incidence of phantom limb and/or stump pain will be significantly decreased four weeks following multiple-day ambulatory continuous peripheral nerve blocks as compared with patients receiving standard-of-care treatment.

Hypothesis 2: Following upper or lower extremity amputation, the severity of phantom limb and/or stump pain will be significantly decreased four weeks following multiple-day ambulatory continuous peripheral nerve blocks as compared with patients receiving standard-of-care treatment (as measured on the 11-point numeric rating scale).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • undergoing unilateral surgical amputation of the upper or lower extremity including at least one metacarpal or metatarsal bone, respectively
  • currently without phantom limb and/or stump pain in a previously-amputated limb
  • ages 18 years or older
  • desiring perineural infusion for up to 6 days
  • willing to have an ambulatory infusion following hospital discharge

排除标准

  • hepatic or renal failure
  • allergy to the study medications
  • pregnancy
  • incarceration
  • possessing a contraindication to perineural catheter placement or perineural local anesthetic infusion

研究组 & 干预措施

1. standard care

Placebo Comparator

1 day of perineural ropivacaine 0.2% infusion followed by 4-5 days of normal saline infusion.

干预措施: perineural ropivicaine (Procedure)

2: experimental care

Active Comparator

4-5 days of perineural ropivacaine 0.4% infusion.

干预措施: perineural ropivicaine (Procedure)

结局指标

主要结局

The primary outcome measurement will be the difference in average NRS (as administered as part of the Brief Pain Inventory) at 4 weeks between the two treatment groups.

时间窗: Week 4

次要结局

  • Pain and Physical functioning: Brief Pain Inventory (includes the 11-point numeric rating scale of pain intensity)(Preoperative, then days 3, 8, 28, 84, and 365)
  • Emotional Functioning: Beck Depression Inventory(Preoperative, then days 28 and 365)
  • The incidence of phantom limb and/or stump pain will be significantly decreased four weeks following multiple-day ambulatory continuous peripheral nerve blocks as compared with patients receiving standard-of-care treatment.(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian M. Ilfeld, MD, MS

Associate Professor, In Residence

University of California, San Diego

研究点 (2)

Loading locations...

相似试验